320
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Azithromycin Misuse During the COVID-19 Pandemic: A Cross-Sectional Study from Jordan

ORCID Icon & ORCID Icon
Pages 747-755 | Published online: 02 Mar 2022

References

  • Zhu H, Wei L, Niu P. The novel coronavirus outbreak in Wuhan, China. Glob Health Res Policy. 2020;5:6. doi:10.1186/s41256-020-00135-6
  • World Health Organization Regional Office for Europe. Health topics: WHO announces COVID-19 outbreak a pandemic; 2020. Available from: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/news/news/2020/3/who-announces-covid-19-outbreak-a-pandemic. Accessed November 5, 2021.
  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi:10.1016/S0140-6736(20)30183-5
  • Touret F, Gilles M, Barral K, et al. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. Sci Rep. 2020;10(1):13093. doi:10.1038/s41598-020-70143-6
  • Schönfeld W, Kirst HA. Effects of Macrolide Antibiotics on Ribosome Function. Basel: Birkhäuser Verlag; 2002.
  • Damle B, Vourvahis M, Wang E, et al. Clinical Pharmacology perspectives on the antiviral activity of azithromycin and use in COVID-19. Clin Pharmacol Ther. 2020;108:201–211. doi:10.1002/cpt.1857
  • Gyselinck I, Janssens W, Verhamme P, et al. Rationale for azithromycin in COVID-19: an overview of existing evidence. BMJ Open Resp Res. 2021;8:e000806. doi:10.1136/bmjresp-2020-000806
  • Oliver ME, Hinks TSC. Azithromycin in viral infections. Rev Med Virol. 2021;31(2):e2163. doi:10.1002/rmv.2163
  • Kawamura K, Ichikado K, Takaki M, Eguchi Y, Anan K, Suga M. Adjunctive therapy with azithromycin for moderate and severe acute respiratory distress syndrome: a retrospective, propensity score‐matching analysis of prospectively collected data at a single center. Int J Antimicrob Agents. 2018;51(6):918‐924. doi:10.1016/j.ijantimicag.2018.02.009
  • Arabi YM, Deeb AM, Al-Hameed F, et al. Macrolides in critically ill patients with Middle East Respiratory Syndrome. Int J Infect Dis. 2019;81:184–190. doi:10.1016/j.ijid.2019.01.041
  • Ali AS, ASattar MA, Karim S, et al. Pharmacological basis for the potential role of Azithromycin and Doxycycline in management of COVID-19. Arab J Chem. 2021;14(3):102983. doi:10.1016/j.arabjc.2020.102983
  • Kim H, Walker D, Dredze M, Sangraula A, Smith MC, Quinn SC. Leveraging volunteer fact checking to identify misinformation about COVID-19 in social media. Harv Kennedy Sch Misinformation Rev. 2020;1(3). doi:10.37016/mr-2020-38
  • Ministry of Health (Jordan). “COVID-19 statistical report”. 2021.
  • Almaaytah A, Mukattash TL, Hajaj J. Dispensing of non-prescribed antibiotics in Jordan. Patient Prefer Adherence. 2015;9:1389. doi:10.2147/PPA.S91649
  • Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis. 2011;11(9):692–701. doi:10.1016/S1473-3099(11)70054-8
  • RAOSOFT. Sample size calculator 2020. Available from: http://www.raosoft.com/samplesize.html. Accessed March 2, 2020.
  • Awad AI, Aboud EA, Singer AC. Knowledge, attitude and practice towards antibiotic use among the public in Kuwait. PLoS One. 2015;10(2):e0117910. doi:10.1371/journal.pone.0117910
  • Worldometer. Coronavirus statistics: Jordan; 2021. Available from: https://www.worldometers.info/coronavirus/country/jordan/. Accessed May 1, 2021.
  • de Lusignan S, Joy M, Sherlock J, et al. PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship. medRxiv. 2021. doi:10.1101/2021.02.02.21250902
  • Sulis G, Batomen B, Kotwani A, Pai M, Gandra S. Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: an interrupted time series analysis. PLoS Med. 2021;18(7):e1003682. doi:10.1371/journal.pmed.1003682
  • Elsayed AA, Darwish SF, Zewail MB, Mohammed M, Saeed H, Rabea H. Antibiotic misuse and compliance with infection control measures during COVID-19 pandemic in community pharmacies in Egypt. Int J Clin Pract. 2021;75(6):e14081. doi:10.1111/ijcp.14081
  • World Health Organization. Clinical Management of COVID-19: Interim Guidance. World Health Organization; 2020.
  • Sharma S, Singh A, Banerjee T. Antibacterial agents used in COVID-19: a systematic review and meta-analysis. Environ Sustain. 2021;4:503–513. doi:10.1007/s42398-021-00194-6
  • Kuang L, Liu Y, Wei W, et al. Non-prescription sale of antibiotics and service quality in community pharmacies in Guangzhou, China: a simulated client method. PLoS One. 2020;15(12):e0243555. doi:10.1371/journal.pone.0243555
  • Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York city. N Engl J Med. 2020;382(24):2372–2374. doi:10.1056/NEJMc2010419
  • Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622–1629. doi:10.1016/j.cmi.2020.07.016
  • Chi SY, Kim TO, Park CW, et al. Bacterial pathogens of ventilator associated pneumonia in a tertiary referral hospital. Tuberc Respir Dis. 2012;73:32–37. doi:10.4046/trd.2012.73.1.32
  • Sivapalan P, Suppli Ulrik C, Sophie Lapperre T, et al. Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19-a randomised double-blinded placebo-controlled trial. Eur Respir J. 2021;59:2100752.
  • Rodrigues C, Freitas-Santos RS, Levi JE, et al. Hydroxychloroquine plus azithromycin early treatment of mild COVID-19 in an outpatient setting: a randomized, double-blinded, placebo-controlled clinical trial evaluating viral clearance. Int J Antimicrob Agents. 2021;58(5):106428. doi:10.1016/j.ijantimicag.2021.106428
  • Muflih SM, Al-Azzam S, Abuhammad S, Jaradat SK, Karasneh R, Shawaqfeh MS. Pharmacists’ experience, competence and perception of telepharmacy technology in response to COVID-19. Int J Clin Pract. 2021;75(7):e14209. doi:10.1111/ijcp.14209
  • Alkhawaja E, Hammadi S, Abdelmalek M, Mahasneh N, Alkhawaja B, Abdelmalek SM. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study. BMC Dermatol. 2020;20(1):1–9. doi:10.1186/s12895-020-00108-9
  • Okeke IN, Lamikanra A, Edelman R. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis. 1999;5(1):18–27. doi:10.3201/eid0501.990103
  • Malik B, Bhattacharyya S. Antibiotic drug-resistance as a complex system driven by socio-economic growth and antibiotic misuse. Sci Rep. 2019;9:9788. doi:10.1038/s41598-019-46078-y
  • World Health Organization. Newsroom: antibiotic resistance; 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance. Accessed November 4, 2021.
  • [No authors listed]. Antimicrobial resistance in the age of COVID-19. Nat Microbiol. 2020;5(6):779. doi:10.1038/s41564-020-0739-4
  • Abdelmalek SMA, Qinna MW, Al-Ejielat R, Collier PJ. Methicillin-Resistant Staphylococci (MRS): carriage and antibiotic resistance patterns in college students. J Community Health. 2022. doi:10.1007/s10900-022-01065-9